KOMO Biosciences Appoints Biologics Manufacturing Leader Darryl Sampey, PhD, to its Scientific Advisory BoardCAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- KOMO Biosciences today announced the appointment of Darryl Sampey, PhD, to its Scientific Advisory Board. Dr. Sampey brings more than two decades of experience in biologics development and manufacturing, with deep expertise in cell line and process development, CMC strategy, and advancing complex biopharmaceutical programs.
KOMO Biosciences Grants Research Evaluation License to Syngenta to Explore Precision Genome Modification in MaizeCollaboration brings non-viral, site-specific DNA insertion to crop trait development, intended to accelerate the path to more resilient and sustainable agriculture
